AC Immune (ACIU) Total Non-Current Liabilities (2014 - 2026)

AC Immune (ACIU) has reported Total Non-Current Liabilities for 12 consecutive years, with $17.4 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 91808.1% year-over-year to $17.4 billion; the TTM figure through Mar 2026 stood at $17.4 billion (up 91808.1% YoY), while the FY2025 annual figure was $17.7 billion, up 86979.49% from the prior year.
• Total Non-Current Liabilities slipped to $17.4 billion in Q1 2026 per ACIU's latest filing, from $18.4 billion in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $18.4 billion in Q4 2025 and bottomed at $2.0 million in Q3 2022.
• Historically, Total Non-Current Liabilities has averaged $3.4 billion across 5 years, with a median of $15.1 million in 2024.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities plunged 99.98% — and 2023, when it jumped 170677.33%.
• AC Immune's Total Non-Current Liabilities stood at $5.7 million in 2022, then surged by 170677.33% to $9.7 billion in 2023, then slumped by 99.79% to $20.3 million in 2024, then surged by 90231.36% to $18.4 billion in 2025, then retreated by 5.13% to $17.4 billion in 2026.
• Business Quant data shows ACIU's Total Non-Current Liabilities at $17.4 billion in Q1 2026, $18.4 billion in Q4 2025, and $13.6 million in Q3 2025.